drugset / Trial / NCT02526849

Efficacy and Safety of Fecal Microbiota Transplantation for Slow Transit Constipation

NCT02526849

Phase 2 Unknown 100 enrolled Jinling Hospital, China
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the effect of fecal microbiota transplantation in adults with slow transit constipation.

Timeline

Start
2015-11
Primary completion
2016-12
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Fecal Microbiota Transplantation (FMT) Other / unclassified 100 ml Other

Indications